“Johnson & Johnson boosts heart device business with $12.5 billion Shockwave Medical deal”
April 8, 2024
“Johnson & Johnson on Friday agreed to buy Shockwave Medical for $12.5 billion in a deal that would help broaden its portfolio of medical devices used in treating heart diseases.
The acquisition gives J&J access to a device that uses shockwaves to break down calcified plaque in heart vessels, similar to how kidney stones are treated.
The conglomerate is focusing on building its cardiac health business and spent $16.6 billion to buy heart pump maker Abiomed in 2022 and $400 million to buy another heart-centric device maker Laminar…”
https://www.cnbc.com/2024/04/05/johnson-johnson-to-buy-shockwave-medical-for-12point5-billion.html